Regeneron Pharmaceuticals, Inc. (REGN)
774.89
+19.98
(+2.65%)
USD |
NASDAQ |
Feb 11, 13:57
Regeneron Pharmaceuticals Profit Margin (Quarterly) : 21.74% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 13.51% |
| Gilead Sciences, Inc. | 39.21% |
| Johnson & Johnson | 20.83% |
| Eli Lilly & Co. | 34.40% |
| Merck & Co., Inc. | 18.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.93% |
| Return on Assets | 11.59% |
| Return on Invested Capital | 13.66% |
| Gross Profit Margin (Quarterly) | 81.22% |
| Operating Margin (Quarterly) | 23.13% |
| Return on Net Operating Assets | 29.72% |